Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.
OriginalsprogEngelsk
TidsskriftExcerpta Medica. Section 31: Arthritis and Rheumatism
Vol/bind65
Udgave nummer5
Sider (fra-til)1213-23
Antal sider11
ISSN0014-4355
DOI
StatusUdgivet - maj 2013

ID: 38610876